BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 29342133)

  • 21. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
    Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
    Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction.
    Sandler VM; Lis R; Liu Y; Kedem A; James D; Elemento O; Butler JM; Scandura JM; Rafii S
    Nature; 2014 Jul; 511(7509):312-8. PubMed ID: 25030167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.
    Tanaka S; Miyagi S; Sashida G; Chiba T; Yuan J; Mochizuki-Kashio M; Suzuki Y; Sugano S; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood; 2012 Aug; 120(5):1107-17. PubMed ID: 22677129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.
    Santos MA; Faryabi RB; Ergen AV; Day AM; Malhowski A; Canela A; Onozawa M; Lee JE; Callen E; Gutierrez-Martinez P; Chen HT; Wong N; Finkel N; Deshpande A; Sharrow S; Rossi DJ; Ito K; Ge K; Aplan PD; Armstrong SA; Nussenzweig A
    Nature; 2014 Oct; 514(7520):107-11. PubMed ID: 25079327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors.
    Mercer EM; Lin YC; Benner C; Jhunjhunwala S; Dutkowski J; Flores M; Sigvardsson M; Ideker T; Glass CK; Murre C
    Immunity; 2011 Sep; 35(3):413-25. PubMed ID: 21903424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia.
    Basilico S; Göttgens B
    J Mol Med (Berl); 2017 Jul; 95(7):719-727. PubMed ID: 28429049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of embryonic haematopoietic multipotency by EZH1.
    Vo LT; Kinney MA; Liu X; Zhang Y; Barragan J; Sousa PM; Jha DK; Han A; Cesana M; Shao Z; North TE; Orkin SH; Doulatov S; Xu J; Daley GQ
    Nature; 2018 Jan; 553(7689):506-510. PubMed ID: 29342143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
    Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
    Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model.
    Ng RK; Kong CT; So CC; Lui WC; Chan YF; Leung KC; So KC; Tsang HM; Chan LC; Sham MH
    J Pathol; 2014 Jan; 232(1):65-74. PubMed ID: 24122813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
    Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
    EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
    Guo H; Ma O; Friedman AD
    J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene coexpression analysis in single cells indicates lymphomyeloid copriming in short-term hematopoietic stem cells and multipotent progenitors.
    Gautreau L; Boudil A; Pasqualetto V; Skhiri L; Grandin L; Monteiro M; Jais JP; Ezine S
    J Immunol; 2010 May; 184(9):4907-17. PubMed ID: 20368277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of Asxl2 leads to myeloid malignancies in mice.
    Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
    Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediator kinase inhibition further activates super-enhancer-associated genes in AML.
    Pelish HE; Liau BB; Nitulescu II; Tangpeerachaikul A; Poss ZC; Da Silva DH; Caruso BT; Arefolov A; Fadeyi O; Christie AL; Du K; Banka D; Schneider EV; Jestel A; Zou G; Si C; Ebmeier CC; Bronson RT; Krivtsov AV; Myers AG; Kohl NE; Kung AL; Armstrong SA; Lemieux ME; Taatjes DJ; Shair MD
    Nature; 2015 Oct; 526(7572):273-276. PubMed ID: 26416749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.
    Aranda-Orgilles B; Saldaña-Meyer R; Wang E; Trompouki E; Fassl A; Lau S; Mullenders J; Rocha PP; Raviram R; Guillamot M; Sánchez-Díaz M; Wang K; Kayembe C; Zhang N; Amoasii L; Choudhuri A; Skok JA; Schober M; Reinberg D; Sicinski P; Schrewe H; Tsirigos A; Zon LI; Aifantis I
    Cell Stem Cell; 2016 Dec; 19(6):784-799. PubMed ID: 27570068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.
    Liau WS; Ngoc PC; Sanda T
    Adv Exp Med Biol; 2017; 962():139-147. PubMed ID: 28299656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.
    Yilmaz OH; Valdez R; Theisen BK; Guo W; Ferguson DO; Wu H; Morrison SJ
    Nature; 2006 May; 441(7092):475-82. PubMed ID: 16598206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.